Efficacy and Safety of Androgen-Deprivation Therapy Combined with Docetaxel Plus Prednisone in High-Burden Metastatic Hormone-Sensitive Prostate Cancer

PURPOSE: The aim of this study was to evaluate the efficacy and safety of hormonal and synchronous docetaxel plus prednisone (DocP) in metastatic hormone-sensitive prostate cancer (mHSPC). METHODS: One hundred fifty-one cases with high-burden mHSPC diagnosed at 1 single center from January 2014 to A...

詳細記述

保存先:
書誌詳細
出版年:Cancer Manag Res
主要な著者: Hu, Linjun, Zhao, Qinxin, Bai, Hongsong, Xie, Chengming, Shan, Xingli, Lu, Dehu, Chen, Yonghai, Han, Dongdong, Xiao, Zejun, Tian, Jun, Wang, Dong, Bi, Xingang, Xing, Nianzeng
フォーマット: Artigo
言語:Inglês
出版事項: Dove 2020
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7293408/
https://ncbi.nlm.nih.gov/pubmed/32606932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S243843
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料